Long-term safety of Mometasone Furoate administered via a dry powder inhaler in children: Results of an open-label study comparing Mometasone Furoate with Beclomethasone Dipropionate in children with persistent asthma

Table 1 Baseline Patient Demographics and Clinical Characteristics

Demographic or Characteristic	MF-DPI 200 μg QD AM (n = 78)	MF-DPI 100 μg BID (n = 74)	BDP 168 μg BID (n = 81)
Age, mean y	8.4	8.1	8.0
Sex, n
Girls	35	26	32
Boys	43	48	49
Race, n
White	66	61	64
Other	12	13	17
Weight, mean kg	34.1	33.2	32.3
Asthma duration, mean y	5.3	4.8	5.1
Theophylline use, n	1	2	0
Baseline % predicted FEV₁, mean	85.2	86.1	87.4

BID = twice daily; BDP = beclomethasone dipropionate; FEV₁ = forced expiratory volume in 1 second; MF-DPI = mometasone furoate administered via a dry powder inhaler; QD AM = once daily in the morning.

ISSN: 1471-2431